The RSI Indicator for CTLT moved out of oversold territory on November 14, 2023. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 24 similar instances when the indicator left oversold territory. In of the 24 cases the stock moved higher. This puts the odds of a move higher at .
The Momentum Indicator moved above the 0 level on December 01, 2023. You may want to consider a long position or call options on CTLT as a result. In of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for CTLT just turned positive on November 14, 2023. Looking at past instances where CTLT's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CTLT advanced for three days, in of 342 cases, the price rose further within the following month. The odds of a continued upward trend are .
CTLT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 58 cases where CTLT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CTLT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for CTLT entered a downward trend on November 10, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CTLT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.821) is normal, around the industry mean (47.989). P/E Ratio (208.333) is within average values for comparable stocks, (60.542). Projected Growth (PEG Ratio) (2.584) is also within normal values, averaging (2.883). CTLT has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.027). P/S Ratio (1.670) is also within normal values, averaging (65.502).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CTLT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of delivery technologies and development solutions
Industry PharmaceuticalsOther
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FYC | 59.26 | 0.39 | +0.66% |
First Trust Small Cap Gr AlphaDEX® ETF | |||
WDI | 13.47 | 0.03 | +0.22% |
Western Asset Diversified Income Fund | |||
IWR | 73.97 | 0.11 | +0.15% |
iShares Russell Mid-Cap ETF | |||
XB | 38.78 | N/A | N/A |
BondBloxx B Rated USD Hi Yld Corp Bd ETF | |||
FICS | 31.97 | -0.25 | -0.78% |
First Trust Intl Developed Cap Strth ETF |
A.I.dvisor tells us that CTLT and ELAN have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CTLT and ELAN's prices will move in lockstep.
Ticker / NAME | Correlation To CTLT | 1D Price Change % | ||
---|---|---|---|---|
CTLT | 100% | -0.42% | ||
ELAN - CTLT | 31% Poorly correlated | +3.47% | ||
SIGA - CTLT | 25% Poorly correlated | +3.03% | ||
FLGC - CTLT | 25% Poorly correlated | +6.92% | ||
ALVO - CTLT | 24% Poorly correlated | +0.42% | ||
LFCR - CTLT | 23% Poorly correlated | -1.36% | ||
More |
Ticker / NAME | Correlation To CTLT | 1D Price Change % |
---|---|---|
CTLT | 100% | -0.42% |
pharmaceuticals (undefined stocks) | 27% Poorly correlated | +2.82% |
Pharmaceuticals (undefined stocks) | -0% Poorly correlated | +1.27% |
Pharmaceuticals: Other (undefined stocks) | -0% Poorly correlated | +1.56% |